IPHANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as IPHYF

Innate Pharma SA

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026

$1.46+0.03 (+2.10%)

Close on Oct 19, 2026

Innate Pharma SA revenue by segment

Innate Pharma does not break out revenue by segment, region or product in the tagged data of its filings for this period type.